Targeting cancer by binding iron: Dissecting cellular signaling pathways
about
The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targetsPhytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathology2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implicationsDeferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease.Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.Emodin inhibits migration and invasion of MHCC-97H human hepatocellular carcinoma cells.Iron chelators target both proliferating and quiescent cancer cells.TES inhibits colorectal cancer progression through activation of p38.Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors.Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism.Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.Siderophores in Iron Metabolism: From Mechanism to Therapy Potential.Iron overload and altered iron metabolism in ovarian cancer.The transferrin receptor: the cellular iron gate.BRAF mutations are associated with increased iron regulatory protein-2 expression in colorectal tumorigenesis.L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents.Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.The relationship between iron bone marrow stores and response to treatment in pediatric acute lymphoblastic leukemia.Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells.Six-Transmembrane Epithelial Antigen of Prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion.Artemisinin and Its Synthetic Derivatives as a Possible Therapy for Cancer.Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo.Cancer cell death induced by ferritins and the peculiar role of their labile iron pool.Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star
P2860
Q26782593-2DCE98A3-C632-465E-B764-0BD28D183124Q26863390-379E52B0-09CF-42B2-A1DD-58CC1BA448F7Q30239808-527C067F-F137-49D3-8153-0FCB9FC40977Q36119319-7C7A6173-0966-4810-AD4E-8E923D4142B4Q36665139-676CC24E-B389-41D1-AE46-A630F209749DQ36852491-8CEFF07B-F92D-4AB8-BA98-3D9AFFA96B9DQ37406594-9AA870CB-7D08-4B0B-9E11-372E9E2C7B2EQ37479772-8224826C-2E0D-47D9-A331-14BC071DA165Q37564565-E3B56508-CCD7-48DA-A160-D45E04A5B936Q37690976-75A553F3-1F9E-4D87-B86F-C6E078108AA9Q37701609-3C0983B8-0651-4EBD-B592-BEF3FA052C14Q38771232-C3FE3751-D4B1-462A-920C-1E94119AE705Q39003164-75234F27-705C-4CB0-A597-D7BEAEC88F34Q39092091-BEB7D2E1-EE4A-44E4-A5A6-9B544765701FQ39410864-5642FB59-1054-4607-B16B-0166A80D5C1EQ41071955-6D653FFA-6CEB-47E8-983E-BC9E75F99DE9Q41784579-A89AB046-96B6-445E-95FF-FC4E532149E9Q46419763-F985618A-7222-4C95-A685-6A6F05176CF0Q47094715-B4EA0033-6CA2-4936-8333-EC991445463DQ47097927-EAD06F5B-54DE-4C6E-82EA-18FF261479AFQ55040339-7536FAA5-7F38-4DA8-96BA-B30D17BB34D2Q55404606-335B5A86-BF6D-495F-893C-81FEC24016DEQ55447773-C9A1991E-135B-4D64-98A1-D4C0C68481C9Q55452485-98C46B4E-999D-46E1-92FD-EABAE2B40944Q57109348-0A7C2020-EA66-4057-8833-FFA398CB4DE5
P2860
Targeting cancer by binding iron: Dissecting cellular signaling pathways
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeting cancer by binding iron: Dissecting cellular signaling pathways
@ast
Targeting cancer by binding iron: Dissecting cellular signaling pathways
@en
type
label
Targeting cancer by binding iron: Dissecting cellular signaling pathways
@ast
Targeting cancer by binding iron: Dissecting cellular signaling pathways
@en
prefLabel
Targeting cancer by binding iron: Dissecting cellular signaling pathways
@ast
Targeting cancer by binding iron: Dissecting cellular signaling pathways
@en
P2093
P2860
P921
P356
P1433
P1476
Targeting cancer by binding iron: Dissecting cellular signaling pathways
@en
P2093
Angelica M Merlot
Danuta S Kalinowski
Goldie Y L Lui
Vera Richardson
P2860
P304
18748-18779
P356
10.18632/ONCOTARGET.4349
P407
P5008
P577
2015-06-23T00:00:00Z
2015-08-07T00:00:00Z